HighTower Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $643K | Sell |
9,787
-11,476
| -54% | -$809K | 0.06% | 136 |
|
|
2022
Q4 | $1.53M | Buy |
21,263
+282
| +1% | +$21.3K | 0.15% | 85 |
|
|
2022
Q3 | $1.49M | Buy |
+20,981
| New | +$1.52M | 0.16% | 82 |
|
|
2022
Q2 | – | Sell |
-20,179
| Closed | -$1.47M | – | 239 |
|
|
2022
Q1 | $1.47M | Buy |
20,179
+373
| +2% | +$25K | 0.14% | 87 |
|
|
2021
Q4 | $1.24M | Buy |
19,806
+3,759
| +23% | +$221K | 0.12% | 93 |
|
|
2021
Q3 | $950K | Buy |
16,047
+161
| +1% | +$10.6K | 0.12% | 80 |
|
|
2021
Q2 | $1.06M | Sell |
15,886
-348
| -2% | -$22.7K | 0.13% | 76 |
|
|
2021
Q1 | $1.02M | Sell |
16,234
-1,454
| -8% | -$90.5K | 0.14% | 71 |
|
|
2020
Q4 | $1.1M | Sell |
17,688
-1,477
| -8% | -$90.8K | 0.16% | 67 |
|
|
2020
Q3 | $1.16M | Sell |
19,165
-2,098
| -10% | -$126K | 0.18% | 65 |
|
|
2020
Q2 | $1.25M | Buy |
21,263
+163
| +0.8% | +$9.75K | 0.19% | 64 |
|
|
2020
Q1 | $1.18M | Buy |
21,100
+3,002
| +17% | +$183K | 0.2% | 64 |
|
|
2019
Q4 | $1.16M | Buy |
18,098
+870
| +5% | +$49.8K | 0.14% | 69 |
|
|
2019
Q3 | $874K | Buy |
17,228
+376
| +2% | +$17.7K | 0.11% | 79 |
|
|
2019
Q2 | $764K | Buy |
16,852
+4,712
| +39% | +$219K | 0.1% | 81 |
|
|
2019
Q1 | $579K | Sell |
12,140
-5,000
| -29% | -$249K | 0.07% | 81 |
|
|
2018
Q4 | $891K | Hold |
17,140
| – | – | 0.13% | 67 |
|
|
2018
Q3 | $1.06M | Hold |
17,140
| – | – | 0.12% | 68 |
|
|
2018
Q2 | $949K | Hold |
17,140
| – | – | 0.11% | 78 |
|
|
2018
Q1 | $1.08M | Hold |
17,140
| – | – | 0.13% | 64 |
|
|
2017
Q4 | $1.05M | Hold |
17,140
| – | – | 0.12% | 65 |
|
|
2017
Q3 | $1.09M | Sell |
17,140
-270
| -2% | -$15.8K | 0.13% | 57 |
|
|
2017
Q2 | $970K | Hold |
17,410
| – | – | 0.11% | 64 |
|
|
2017
Q1 | $946K | Hold |
17,410
| – | – | 0.11% | 76 |
|
|
2016
Q4 | $1.02M | Buy |
17,410
+5,000
| +40% | +$273K | 0.11% | 74 |
|
|
2016
Q3 | $669K | Hold |
12,410
| – | – | 0.08% | 88 |
|
|
2016
Q2 | $913K | Hold |
12,410
| – | – | 0.1% | 74 |
|
|
2016
Q1 | $793K | Hold |
12,410
| – | – | 0.1% | 71 |
|
|
2015
Q4 | $854K | Sell |
12,410
-10,000
| -45% | -$661K | 0.11% | 66 |
|
|
2015
Q3 | $1.33M | Buy |
22,410
+10,000
| +81% | +$634K | 0.22% | 39 |
|
|
2015
Q2 | $826K | Sell |
12,410
-1,400
| -10% | -$92.3K | 0.13% | 55 |
|
|
2015
Q1 | $891K | Sell |
13,810
-560
| -4% | -$35.1K | 0.14% | 50 |
|
|
2014
Q4 | $848K | Hold |
14,370
| – | – | 0.13% | 53 |
|
|
2014
Q3 | $735K | Hold |
14,370
| – | – | 0.11% | 61 |
|
|
2014
Q2 | $697K | Sell |
14,370
-600
| -4% | -$29.6K | 0.09% | 86 |
|
|
2014
Q1 | $778K | Hold |
14,970
| – | – | 0.11% | 79 |
|
|
2013
Q4 | $796K | Sell |
14,970
-255
| -2% | -$13K | 0.1% | 93 |
|
|
2013
Q3 | $705K | Sell |
15,225
-1,720
| -10% | -$75.5K | 0.11% | 76 |
|
|
2013
Q2 | $757K | Buy |
+16,945
| New | +$736K | 0.12% | 53 |
|
Other funds holding BMY
HighTower Trust's BMY Position: Q1 2023 in Review
HighTower Trust reduced its Bristol-Myers Squibb (BMY) stake by 54% in Q1 2023, selling an estimated $809K and leaving 9,787 shares worth $643K. The position accounts for 0.06% of the portfolio, ranked #136.
HighTower Trust first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.53M in Q4 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- HighTower Trust held 9,787 shares of Bristol-Myers Squibb worth $643K as of Q1 2023.
- HighTower Trust sold 11,476 Bristol-Myers Squibb shares in Q1 2023, an estimated $809K.
- Bristol-Myers Squibb made up 0.06% of HighTower Trust's portfolio in Q1 2023, its #136 holding.
- HighTower Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
- HighTower Trust's Bristol-Myers Squibb position peaked at $1.53M in Q4 2022.
- 2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.